The generic name of Methuselah Capsules is Risedronate Sodium Capsules, which can be used for the treatment and prevention of osteoporosis in postmenopausal women. The main ingredient in Risedronate Sodium Capsules is Risedronate Sodium, which is able to bind with hydroxyapatite in bone and has the effect of inhibiting bone resorption, and at the cellular level, this product can inhibit osteoclasts. Postmenopausal women can use it to prevent and treat osteoporosis. Adverse reactions to risedronate sodium capsules include dyspepsia, which may cause digestive disorders such as dysphagia, esophagitis, esophageal or gastric ulcers, as well as diarrhea, abdominal pain, and nausea. In addition, flu-like syndromes such as headache and dizziness may occur. It should be noted that known hypersensitivity to the product, patients with hypocalcemia, those who are difficult to adhere to standing or sitting position within 30 minutes should be prohibited, severe renal impairment should be used with caution, lactating women should stop or stop breastfeeding, and should not be taken with aspirin or non-steroidal anti-inflammatory drugs. The specific use of risedronate sodium capsules is recommended to consult a physician, follow the doctor’s instructions to take, not blindly self-medication.